Clicky

Category Archives: Children’s Health

Scope of Practice: Advantage of Seeing a Family Doctor First

Early in my fourth year of med school, when I was trying to decide what type of residency to apply for, I realized that I enjoyed the breadth of the scope of practice a family physician embraces.  I tell my patients that I specialize in what they walk through the door with. As a family physician I have to be comfortable and competent at seeing nearly any patient for any problem and helping them access the care that they need for the problem they present asking for help with.  In addition I have to try to recognize problems or health risks that they may not recognize, and have to find a way to let my patients accept what I feel is appropriate preventative care and disease management.  I need to be familiar with a vast array of medications, from psyllium to pradaxa, and problems from PSVT to psychogenic cough.

I often am asked by patients if they should come see me or if they should just go directly to the specialist they feel is going to be able to definitively address their concern. I don’t mean to sound pompous here, but often patients are way off base in choosing the specialist best suited to their problem. Seeing a specialist in an arena of healthcare different from your problem has several risks.  These include significant delay in receiving appropriate care, incurring the expense of extensive testing in their area of interest prior to reaching the specialist appropriate to your circumstances, overdiagnosis, and missing related or unrelated problems that a family physician may recognize but a sub-specialist may not notice.  Let’s go through these in more detail:

  • Delay in Receiving Appropriate Care:  This can be the result of various causes.  The one most concerning to me is when a patient makes a self-diagnosis and sees a specialist in that field.  Often symptoms that seem related to one area expertise are caused by a disorder not apparent to the patient.  Epigastric pain and nausea may be the result of heartburn and a gastroenterologist may be suited to evaluate and treat the pain.  On the other hand it may be related to coronary ischemia and need urgent intervention.  Seeing a gastroenterologist is not only not going to help, but may delay care, either because of a longer time to get an appointment for evaluation or because specialists often extensively evaluate issues in their area of concern prior to referral to another specialist. The time to have a trial of a medication for acid reflux and have an endoscopic exam of the esophagus and stomach may be detrimental to the care of a patient with coronary disease.
  • Incurring Expensive Testing:  When a patient sees a family physician they are likely evaluated for the most serious or most likely problems causing their symptoms. The list of potential concerns often extends across several areas of sub-specialty interest. By looking at the most serious and most likely issues first a family physician is more likely to avoid expensive tests for very unlikely problems. An example might be a patient with groin pain.  If this patient sees a family doctor, they will probably be evaluated by history and physical exam for things like inguinal hernia, urologic causes like kidney stone and infection,  hip pathology, in women ovarian-gynecologic issues including ectopic pregnancy, gastrointestinal causes and neurologic causes.  If they see a urologist  they are likely to have extensive evaluation for urologic problems, and may get a correct diagnosis of a kidney stone or UTI.  If their problem very likely a gynecologic problem, they are still likely to have extensive evaluation for the urologic issues because no specialist wants to miss a diagnosis in their field of expertise no matter how low the likelihood may be. This holds true for most specialists.  If you see a sub-specialist you are very likely to have an extensive evaluation for problems in their scope of practice whether or not they think you likely have a problem in their realm.  A family physician is more likely to go through a process of looking for problems they consider important and likely, and put off extensive evaluation for very unlikely diagnoses. The cost savings of the latter approach  can be huge.
  • Overdiagnosis:  I’ll be brief here, but if you have imaging like an MRI, CT scan, ultrasound or even many lab tests abnormalities are often noted that can lead to extensive testing which has its own risks, or diagnosis of a problem that does not now nor will ever bother you. The latter is called overdiagnosis.  See a prior post on overdiagnosis for more information on this topic.  Overdiagnosis may lead to medication side effects, risks of unnecessary procedures, and emotional distress.
  • Missing related or unrelated Problems:  A specialist while highly trained in their scope of practice may not be focused on related or unrelated important health care issues.  If you see a cardiologist it is unlikely that they are going to recognize that you are due for a mammogram and urge you to get a preventative care visit for this and other preventative services you are due. If you see a dermatologist it is unlikely you will bring up your “Oh doctor, by the way I am having these odd numbness and weakness symptoms,” that may lead your family physician to consider a TIA and make interventions to prevent stroke.  The list of similar situations is nearly endless.

I feel pretty strongly that the first point of care for most health concerns should be either your family physician or the emergency department for life threatening emergencies. The scope of practice of your family physician gives you the best chance of efficient, timely and effective care.

Kalydeco: Science at Its Best

I read with a personal interest the approval of Kalydeco (ivacaftor) this week for treatment of the 4% of cystic fibrosis patients carrying the G551D mutation. My first wife Lenore had cystic fibrosis and died at age 26. At that time in 1983 we knew a great deal less about CF than we know now. The introduction of Kalydeco this week brings several key issues in health care to the forefront. Development of drugs to treat disorders with a limited number of patients to use the drug can make the cost to each individual seem crazy expensive. The specific direct targeting of Kalydeco at a specific gene mutation is possibly an indicator of personalized treatments for more common disorders in the future. The whole fast-track process used by the FDA in approval of Kalydeco is an example of their faster approval of some drugs working as promised.

In the years since Lenore’s death CF has been found to be caused by a mutation in the cystic fibrosis trans-membrane conductance regulator  (CFTR) gene that regulates ion transportation (ions like chloride hence the traditional sweat chloride test for CF) and therefore fluid flow within cells. One specific mutation is the G551D mutation (substitution of aspartic acid for glygine at position 551), and the new drug Kalydeco specifically targets the abnormal protein in these specific CF patients. Kalydeco helps the defective protein work more normally, and so reduces the abnormalities in CF patients with this specific mutation.

Unfortunately only about 1 in 25 CF patients have this specific mutation in the CFTR genetic code. The rest have some combination of the other at least 1000 known mutations. The most common CFTR mutation is called F508del (a 3 nucleotide deletion at location 508 leading to a missing phenylalanine amino acid “F”) and about 1 in 30 Caucasians have this specific mutation in the CFTR gene. Kalydeco is not effective in patients who are homozygous for the F508del mutation.  This homozygous F508del mutation is the most common genetic code in CF patients. IN the 4% of CF patients with at least one copy of the G551D mutation Kalydeco has been shown to be effective in reducing CF symptoms, and is an exciting breakthrough.

Patients with the G155D mutation produce a protein that is able to make it to the cell membrane, where Kalydeco allows it to function much more normally.  In patients with the F508del mutation the protein fails to fold in a way that allows it to move to the cell membrane, and so a drug like Kalydeco cannot function.  Scientists are working on possible medications that could allow the migration of the other defective genes to the cell membrane where use in combination with Kalydeco could potentially be effective.

It is exciting not just for the 1200 U.S. patients with this specific type of CF, but also because it is an example of how genetic research, gene analysis in genetic disorders, and great basic science can lead to novel therapy for genetic disorders.

The rapid approval of Kalydeco is a great example of the new expedited FDA approval process for drugs that have the potential to be novel or breakthrough products where there is currently no effective therapy, or the drug is a major advance in therapy.  It took only 3 months for Kalydeco to get FDA approval, even faster than the promised fast-track approval promised for special circumstance drugs.

The catch in this whole process is the incredible anticipated cost of Kalydeco.  In a Wall Street Journal article the estimated annual cost of Kalydeco is reported to be $294,000.  Since the anticipated number of patients eligible to receive this orphan drug is so small, and because of the novel and documented improvements demonstrated in patients using Kalydeco it is expected that insurers will pay for the cost of the medication. If all 1200 eligible patients take Kalydeco the annual cost at this price would be $353 million annually.  Still this price is not Guinness world record. Two more expensive drugs are Soliris for a rare condition parosysmal nocturnal hemoglobinuria at $409K annually and Elaprase for the rare genetic disorder Hunter Syndrome , a polysaccharide storage disorder, at $375K annually. These are examples of orphan drugs with very limited markets where the cost of development is shared by very few patients.

I look forward to seeing more examples of genetic research leading to personalized medications for individuals.

Doctors Die Too, but Maybe Differently

I stumbled across this terrific article titled:

How Doctors Die by Ken Murray a FP at USC.  

It is largely anecdotal, but is a really an interesting perspective on how at least some physicians choose to forgo futile end-of-life treatments because they know the limits of modern medicine first hand.

Also Enjoy:

Octogenerian’s Letter to Santa

 

The Gluten Free Marketplace Explodes

The Gluten Free Marketplace Explodes

Gluten Enteropathy, or celiac disease (sometimes called celiac sprue), is a condition where the lining of the small bowel is damaged by antibodies to gluten found in wheat, rye, barley, malt and some other grains.  When people who are gluten sensitive eat food containing gluten their small bowel becomes inflamed, the villi that contain enzymes to help digest foods to allow their absorption become atrophic and dysfunctional, and they lose weight, become ill and just feel terrible.  For many years it was felt that gluten enteropathy was rare in the United States, and was primarily a European problem.  As late as 1999 the teaching in U.S. medical schools was that only 1:10,000 Americans had gluten enteropathy. Beginning in the early 1990’s research began to show that the incidence was much higher, and it is now estimated that as many as 1:100 Americans has gluten sensitivity.  This for unknown reasons seems to  be a real increase in the last half century, and not be just a product of increased awareness and better testing.

Gluten sensitivity can be dramatic or subtle, and difficult to diagnose.  A battery of blood tests often including Anti-tissue Transglutaminase Antibodies(Anti-tTG) IgA,  Anti-tG IgG, Anti-Gliadin Antibodies, Anti-Endomysial andibodies, or other antibody tests  if positive can suggest the diagnosis. A negative test has a higher predictive value at ruling out celiac disease than a positive test has at confirming the diagnosis (the tests are more highly sensitive than they are specific).  To confirm the diagnosis requires a small bowel biopsy that is usually obtained by upper GI endoscopic exam.

Once diagnosed with celiac disease a person has to learn how to eat a gluten free diet in a society where wheat and other gluten containing food is nearly everywhere.  Fortunately more and more prepared foodstuffs are being marketed all the time, and more recipes, support groups, and nutritional advice is available than ever before.

I just read a very interesting article in the N.Y Times by Keith O’Brien that nicely outlines the history of the emergence of gluten enteropathy in the U.S., and the market leadership by General Foods in bringing gluten free food products to market to capitalize on the growing market for gluten free products.  You may enjoy reading:

 

Should We All Go Gluten Free?

By Keith O’Brien November 25, 2011. 

 

My guess is that you know someone dealing with the need to eat gluten free.  Fortunately as awareness grows and resources become more easily available providing a gluten free meal is less onerous than it was just a decade ago.

I am also learning more about various nutritional deficiencies that can accompany celiac disease.  The malabsorptive condition seen in patients with celiac disease can lead to several well documented vitamin deficiencies that are uncommon otherwise.  Deficiencies in almost all of the fat soluble vitamins and B vitamins are more common in celiac patients than in the general population.  I recently saw a 17 year old girl in the office with known celiac disease who had been well controlled on a gluten free diet for several years. She was found to be both vitamin B12 and folic acid deficient when evaluated for anemia and fatigue.

As a medical community we have become more aware and educated about celiac disease in recent years, and it is good to see that the marketplace is stepping up to meet the demand for gluten free products and make existence easier for this significant minority of Americans with gluten sensitivity.

Cord Blood Stem Cells get FDA Approval as Hemacord™

Yesterday the FDA approved the first cord blood product, to be marketed as Hemacord™ with indications for cord blood stem cell transplant procedures in patient with some types of blood malignancies like leukemia as well as some inherited metabolic and immune system disorders.  I think this could be just the beginning of much more widespread use of cord blood products for therapy.  Cord blood is the blood left in the umbilical cord and the placenta after childbirth.  It is routinely discarded as biologic waste, although in recent years some patents with enough financial means and interest have been having a sample of their newborn infant’s cord blood saved at a cord blood bank, and some public blood banks have begun to collect and store cryopreserved cord blood for public use.  The potential supply of cord blood for therapeutic use would seem to far outweigh the need, and I expect that if cord blood stem cells continue to be as promising as they appear to be, namely as effective as bone marrow or other stem cells for transplant, that their use will become commonplace.

Currently the primary reason cord blood is harvested and stored is by parents trying to insure that if their baby develops a medical condition requiring a stem cell transplant that they will have cord blood available for their therapy.  Cord blood is usually harvested in a “closed” technique, where blood is aspirated from the umbilical vein after the cord is clamped. The blood is then put in an appropriate container and preserved by cryopreservation at a cord blood bank.  When cord blood is saved and stored at a private cord blood bank the cost ranges from $775-$2000 initially with storage fees of about $100/year, making it an expense that many couples cannot afford. The American Academy of Pediatrics currently recommends against encouraging routine cord blood storage in families without a family history of a condition making the need for use of the stored cord blood more likely.  They do recommend collecting and storing cord blood in families with a history of certain hereditary genetic conditions that make it much more likely that the need for use might arise. There has not been a great deal of experience with us of cryopreserved cord blood stored for long periods of time, and concerns about the long-term financial viability of some private companies currently storing cord blood leaves another potential risk that cord blood saved for future use could not be available despite a parent’s best intentions and expense.  The AAP recommends consideration of donation of cord blood to public cord blood banks for availability to the general public.

A recent study showed that use of human cord blood led to similar effects and leukemia-free survival as bone marrow and peripheral blood donor cells.  Currently there are public blood banks that store cord blood, using the “Be the Match Registry” as a central data repository for matching donor cord blood with patients in need.  This gives great hope that now that the New York Blood Center(NYBC) has received FDA approval for Hemacord™ that a much larger set of potential transplant cord blood stem cells may become listed in this or another registry of preserved cord blood with known HLA typing. This could make a source of matching donor cells more readily available for patients who need a stem cell transplant without the current search for an acceptable donor that is currently needed.

A good question is, “Why is the news about Hemacord a big deal since public blood banks are currently saving and storing cord blood.”  One potential benefit is that to obtain FDA licensure of Hemacord the NY Blood Center had to meet rigorous FDA standards for their product in several areas including purity, potency, and efficacy in actual use.  The NYBC’s National Cord Blood Program has been operating since 1996 with an investigational New Drug exemption by the FDA, and the NYBC is rightfully excited about their FDA approval.  This may pave the way for other centers to also get FDA approval and make the use of cord blood stem cell transplantation and potentially other uses of cord blood products much more realistic.  It may also lead to more research of other uses of cord blood therapy. I’ll be interested to see what happens in this field over the next few years.

Sequenom™ brings MaterniT21™ and a Whole New Set of Difficult Choices

Coming to 20 major U.S. metropolitan areas this week will be a test called MaterniT21™  from Sequenom™. Over the past 25 years we’ve gone from alpha-fetoprotein testing, to adding 2, 3 and more recently 4 tests as “penta” screen to try to improve the estimation of  a woman’s risk for having a trisomy-21, or Down’s syndrome pregnancy without actually obtaining fetal cells, but all they have really done is improve statistical prediction capability.  Up to this point in order to tell if a woman is carrying a Down’s Syndrome baby required amniocentesis to obtain amniotic fluid at about 16-18 weeks gestation, or the arguably higher risk chorioamniotic villous sampling at 10-12 weeks gestation.  Both of these tests ran low (estimated 1/350) but real risks of fetal injury and miscarriage.  Now from a company named Sequenom™  comes a test on fetal cells obtained by a venous blood sample of the pregnant women’s blood as early as 10 weeks gestation that can do genetic screening for Down’s Syndrome without more invasive ways to obtain fetal cells.  The initial study of 212 women showed a >99% accuracy rate. (1 false positive, 2 false negatives in 212 women tested).

This is both exciting and frightening. It raises huge questions including who if anyone should get this testing. Here is a list of some of the issues that come to my mind as we start the process of figuring out the role of this new technology:

  1. Increased Abortions and Earlier Abortions of Down’s Syndrome Pregnancies:  One consequence of a more accurate test for Down ’s syndrome if it leads to more widespread testing or women for this condition is that more women will face the decision of abortion or not.  Now women first face the question, “Would I abort my pregnancy if I knew I had Down’s syndrome, and if so am I willing to undergo a test that could cause miscarriage to get that information.”  With the Sequenom™  MaterniT21™  test women will be able to get much more definitive information without a test that puts their fetus at risk from the test itself. This may lead to more women choosing to be tested. Putting aside the whole “pro-life vs. pro-choice” debate, the opportunity for earlier diagnosis will make technically easier and less physically traumatic abortions possible in women who have a Down’s Syndrome pregnancy.
  2. Who should be Eligible for the Test?:  Although the risk of Down ’s syndrome rises with increasing maternal age many Down’s Syndrome babies have young Moms.  With a more accurate and less dangerous test available should all or more women be offered the test?
  3. Who should pay for the testing?: This is a very complicated question.  This test is not going to be inexpensive.  On the Sequenom™  press release they suggest that the cost will approximate the cost of amniocentesis testing.  They do not make it clear if this means the cost of the amniocentesis test itself, the cost of the genetic testing of the cells obtained, or both.  If the test is done it will lead to higher costs for prenatal care as the test itself will significantly increase the overall cost of prenatal care.  On the other hand the cost of having a Down ’s syndrome baby is not inconsequential.  Down ’s syndrome children sometimes have major other congenital deformities, and the long term cost of education, support as adults, and associated family and societal costs are real and significant. A comprehensive cost-benefit analysis of this process will be interesting to see when it becomes available. These issues themselves will lead to ethical and moral choices.
  4. Lower Incidence of Down’s Syndrome:  If this tests becomes widely used, and if more women choose to abort pregnancies with Down’s Syndrome fetuses, the incidence of Down’s Syndrome could significantly decline.  While many may consider this the desired outcome, some Down’s Syndrome supporters fear that this may lead to reduced support and reduced research into drugs and other techniques to help Down’s children.

I’m sure I’ve only touched the surface of the ethical, emotional, medical, moral and financial issues this new MaterniT21™ test from Sequenom™ and likely others to follow will bring.  It seems a near certainty that with the ability to sample fetal cells from maternal blood other genetic tests like tests for cystic fibrosis, sickle cell disease, and many others will follow.

Don’t miss a post, subscribe using the email subscription in the right sidebar.

You may also enjoy:

When No Immediate Treatment is the Best Option for Prostate Cancer

Prayer Saying Goodbye Mom

Moral Responsibility to Get Your Flu Shot

Moral Responsibility to Get Your Flu Shot

 

I Got Mine

This topic comes to mind again this year as we have plenty of influenza vaccine, on time this year and ready for distribution.  A prior version of this post was posted in 2010.  I have strong enough feelings on the subject to repost an updated version.  If anything good came of the Swine Flu epidemic on 2009 it was that more Americans get immunized not than ever before.

This year as every previous year Dr. Pullen was first in line at our office for my influenza vaccination.  I take seriously the mantra primum non nocere, first do no harm. It’s hard to imagine doing more harm than seeing a patient with influenza on Monday, and on Wednesday, the day before I get sick, sneezing and passing the influenza germ to one of my vulnerable older patients, or a pregnant woman, or a young baby who then dies from influenza.  This scenario is just inexcusable given that I could have avoided harming the patient if I had received the recommended and easily available influenza vaccination. It would be immoral and irresponsible to put my patients at that type of risk unnecessarily.  I encourage, coax, tease, and everything short of intimidate my employees and fellow physicians to get their influenza vaccination also.  School teachers, emergency workers, and others in close contact with the public should similarly feel morally compelled to get influenza vaccination. It is our moral responsibility.

I also got a Tdap vaccination last year also, even though was several years until I was due a tetanus shot.  See Dr. Pullen Gets His Tetanus Booster  Shot Years Early!  My thinking was the same, try to avoid a pertussis infection, and not put my patients at risk.

It’s a small step from discussing health care workers and influenza and pertussis vaccination, to talking about parents and childhood vaccinations.  The parent who chooses not to vaccinate their children against measles and pertussis puts not only their own child, but other children in the community and the school who may be at particular risk for complications from these infections in danger.  These children at high risk may catch these infections from these unimmunized children.  As a parent I’d feel terrible if my child died or became brain injured from measles, but I’d also feel horrible if my child passed Pertussis or measles on to a child with leukemia, or HIV because I chose to not immunize my child.  I appreciate that this is a free society, and we can make our own personal choices about health care including immunizations. It’s not illegal to decline recommended immunizations, but in many cases it is irresponsible and not living up to our community moral responsibility. Parents who choose not to immunize their children and take advantage of the herd immunity of the majority of children whose parents responsibly immunize their kids are just ignorantly selfish.  They think they are protecting their children from risks of immunizations, though a great mass of evidence refutes this point of view.  In fact they are putting both their own child, and other children who lack immunity through no choice of their own or their parents at risk.

I’m anticipating a rash of angry comments calling me a mouthpiece of the brainwashed physicians of organized medicine.  Don’t believe them.

See these references on the safety of childhood immunizations.

Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism  (there is none).

Data Fail to Support Thimerosal-Autism Link

The end of the autism/vaccine debate?

Book Is Rallying Resistance to the Antivaccine Crusade

Also see the great video at the top of the Musical Docs page Immunize: The Vaccine Anthem.

You may also enjoy:

Dr. Pullen Got His Tetanus Booster Years Early! 

Polio Eradication 

Subscribe to DrPullen.com using the email sign up in the column at the right.

 

 

 

 

Which Argument Shoots Down Your Excuse for Not Getting a Flu Shot.

Got My Flu Shot Today

I really don’t like the term “flu” or “flu shot” because the term flu should not be used interchangeably with “viral illness.” Influenza is a specific, often very severe and even deadly viral illness and influenza vaccine is a very specific vaccine.  Still the term flu shot is so integral to our everyday language that I’ll us the term, and encourage all of you to GET YOUR FLU SHOT.  I hear excuses every day during the fall and early winter when I offer influenza vaccine to my patients.   Here are some of the most common excuses (explanations?) I hear and my explanation  (argument?) of the folly in that line of reasoning.

  1. “I never get the flu.  I don’t need a flu shot.”    –  Most people only get influenza once every several years.  It is not unusual for any given individual to go 10-15 years without contacting influenza.  Influenza is a severe illness much of the time and it is worth getting a flu shot every year to prevent one case of influenza every 10-20 years.
  2. “The last time I got a flu shot I got the flu.”  –  This is just not true.  An influenza vaccine simply does not cause influenza. Since the influenza vaccine contains a killed virus, it is not possible for it to cause influenza.During the season when we give flu shots minor illnesses are common.  It is not unusual to become ill during the time shortly after getting a flu shot.  Also a small percentage of people who get a flu shot may have some minor aching, low grade fever or malaise.  This is not even close to as severe a problem as a real case of influenza, and is no reason not to get a flu shot.
  3. “I just don’t like shots,” or   “I hate needles,”  or “Shots hurt.” –  Nobody likes getting shots, or being stuck with a needle.  The benefits of influenza vaccine, both for yourself and for those you care about are important enough to suffer through an injection. Just get it over with.
  4. “I heard the flu shot this year is just the same as last year so I don’t need another shot.”  –  I heard this today from a medical student at the office.  They should know better, and I tried to set them straight.  It is true, that in 2011 the components of the influenza vaccine are the same as they were in 2010.  I suspect that this student was just trying to find an excuse not to get a shot.  It is good news that the vaccine has not changed this year. First it means that no new and very different influenza virus lurking and ready to cause a severe influenza pandemic was discovered.  Getting a second vaccine will be the equivalent of a booster shot, making you even more immune to these strains of influenza, whereas the remaining immunization from last year’s flu vaccine are not adequate to provide immunity sufficient to prevent contacting influenza this year.
  5. “I’m healthy and if I get the flu I won’t get all that sick.”  — I’m happy that you are a healthy person who takes good care of yourself.  Now get a flu shot and stay healthy, because influenza can be very severe or even lethal for even the strongest and healthiest of us.  In addition if you catch influenza you will be putting others at risk.  You’ll be sick enough that someone will need to take care of you, and they will be at risk needlessly because you chose not to be immunized.  This is especially true if you are around the elderly, the very young, pregnant women, or persons with chronic disease.  Respect yourself and those around you and get a flu shot.
  6. “I want to leave my immune system alone so I will develop good immunity naturally.  If I get a flu shot I weaken my immune system.”  – - This is just faulty reasoning.  There is no evidence to suggest that getting an influenza vaccination reduces your immunity against other germs.  It simply provides antibodies against certain strains of influenza A and B.  This immunity likely is increased by annual flu shots, so that by getting a flu shot annually you develop better influenza immunity each year.

Last year I posted on The Social and Moral Responsibility of Immunizations  for health care workers, teachers and others in positions where others at high risk may be exposed to them if they contact influenza.  I wrote earlier this year on the Flu Season.   This health blog also links to an AFP article on The 12 Basic Rules of Influenza and I wrote on how to Avoid Getting Sick.  I hopt that all of these are informative, but if I could accomplish one thing with this blogging effort, I’d convince every one of my patients and readers (except the uncommon patients with severe egg allergy or other valid reason to need to rely on the herd immunity that could occur if the rest of us got immunized) to get an influenza vaccination every year.  If I could do that I’d feel that I’d have made a real difference in the tiny part of the world that I touch.

Saline, Oral Rehydration and Neti Pot Solution Recipes

There may be lots or reasons you want to make homemade saline solution, oral electrolyte rehydration solution, Neti pot sinus irrigation solution instead of going to the pharmacy to buy it premade.  It may be late at night or a holiday and the stores may be closed, you may not have transportation, or you may just want to save money or feel self-sufficient.  Whatever the reason you can safely make your own solutions for these purposes, but keep in mind that the concentrations of the various salts in these solutions needs to be accurately measured and mixed or you can do yourself or your child significant harm.  That said here are recipes for these commonly recommended medicinal solutions.

Saline Solution Recipe:  This is also called normal saline, or physiologic saline solution.  The names all mean that the concentration of sodium chloride in the solution is very close to the same concentration of salts dissolved in the cells of the body, so the solution does not cause water to pass into or out of cells it comes into contact with leading to cell dehydration or swelling.         This recipe is recommended for irrigation of wounds, soaking ingrown toenails, and such uses, but not for contact lens care or other uses where strict sterility is needed.   For these “clean” but not sterile uses tap water is adequate.  Better to use distilled water, but tap water is OK for most uses.

  • 1/3 tsp non-iodized salt +250 ml boiled or distilled water (one cup is 240 ml and is close enough for most purposes.
  • For larger amounts use 1 liter boiled or distilled water + 1 1/3 tsp non-iodized salt.

Oral Electrolyte Solution Recipe:  Oral Electrolyte Rehydration solution is among the most important advances in prevention of death worldwide from diarrhea.  It has revolutionized the management of infant diarrhea and probably prevented more deaths than most much more widely acclaimed advances in medical care.  It is estimated that the use of oral rehydration solution and zinc tablets has prevented 50 million infant deaths in the last 25 years.  There are many recipes out there for homemade oral electrolyte solution, but this one is simple, is recommended by the Rehydration Project supported by the World Health Organization, and works fine:

  • 1 liter clean water
  • 6 level teaspoons of sugar
  • ½ level teaspoon of salt

Neti Pot Solution Recipe:   Neti pots are very popular, have almost a cult following, and work fine, but personally I prefer one of the simple nasal saline rince devices like the NeilMed Sinus Rinse product.  It is very easy to use, and the key is to be gentle in the irrigation and in the blowing out of the solution after irrigation.  Here is a recipe that works great for saline irrigation:

  • 1 liter of lukewarm distilled water
  • 1 tsp non-iodized salt.  Sea salt or kosher salt are good options.
  • ½ tsp baking soda.
  • Mix the ingredients until the soda and salt are dissolved.

 

If you decide to use any of these solution recipes remember that they need to be measured accurately and you need to use common sense.  If you are getting worse not better, consult your physician.  If you feel more comfortable using premade solutions at the pharmacy by all means buy them. If you want to make them yourself be sure to wash your hands carefully, take care to avoid contaminating the solutions, and do not store the solutions for future use, rather mix them fresh to avoid bacterial contamination and growth.

Baby Teeth Are Important

Baby teeth are much more important to overall health and the development of strong and healthy adult teeth than many people realize. Babies are almost always born without teeth, and begin the process of teething usually between 2 and 12 months of age. The first teeth to erupt are usually the bottom two central incisors, followed in order by the top two central incisors, the top outer incisors, the bottom outer incisors and then the then the first molars. These are followed by the canine or eye teeth and then at about 3 years of age the second molars. There are 20 baby teeth, also called deciduous teeth because they are shed, just like the leaves of deciduous trees.
The baby teeth play several key roles. One of the key functions of the baby teeth is to hold space open for the permanent teeth. If you baby develops serious dental decay and loses some of their baby teeth early the growth and formation of the jaw can be altered making less space for the permanent teeth and lead to orthodontic issues. In addition if a child develops caries in their baby teeth they are more prone to develop caries in their subsequent permanent teeth because of the colonization of the mouth with the bacteria that lead to plaque and caries.
So what can you do to keep your child’s baby teeth healthy and cavity free? There are several important aspects, some may seem intuitive, others less so. Here are some of the key things to do and to avoid:

  •  Brush your child’s teeth at least twice a day. Start as soon as the first teeth erupt. Avoid using excessive amounts to fluorinated toothpaste. Use a grain of rice amount or less. If your child wants to brush their own teeth that’s great, but you need to also brush them as young children are not able to do an adequate job. Tell your child that they can brush but that you will polish after they finish.
  •  Seek dental care early. Some experts recommend a dental visit at age 1. Most recommend by age 3 at the latest, but about age 2 years is usually recommended. The dentist will look for problems, clean away any plaque, and do fluoride treatments that are very effective at preventing decay.
  • Make sure your child gets fluoride supplementation. Some physicians recommend prenatal fluoride though this is not widely done there is some evidence of efficacy in prevention of cavities in the baby teeth. If your local water does not have fluoride added, ask your babies doctor for a fluoride supplement starting at age 6 months. This should be continued until all the permanent teeth are grown.
  • Do not give your baby a bottle with any milk or sugar to use in the crib. Finish the bottle prior to going to sleep to avoid bottle caries. This is a really important factor.
  •  If you use a pacifier don’t dip it is honey, sugar water or anything with sugar. Also don’t put it in your mouth, as the germs that cause cavities are passed from parent to child easily.
  •  Start using dental floss as soon as the teeth get close to each other.
  •  If you child develops carries, be aggressive in getting dental care to prevent further decay and premature loss of the baby teeth.

Overall the key lesson is that baby teeth are important and good care of the baby teeth can give a child a big advantage in the likelihood of having healthy and well aligned permanent teeth.